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Human infection with highly pathogenic avian influenza viruses (HPAIV) is often associated
with severe tissue damage due to hyperinduction of interferons and proinflammatory
cytokines. The reasons for this excessive cytokine expression are still incompletely
understood, which has hampered the development of efficient immunomodulatory
treatment options. The host protein TRIM28 associates to the promoter regions of
over 13,000 genes and is recognized as a genomic corepressor and negative immune
regulator. TRIM28 corepressor activity is regulated by post-translational modifications,
specifically phosphorylation of S473, which modulates binding of TRIM28 to the
heterochromatin-binding protein HP1. Here, we identified TRIM28 as a key immune
regulator leading to increased IFN-β and proinflammatory cytokine levels during infection
with HPAIV. Using influenza A virus strains of the subtype H1N1 as well as HPAIV
of subtypes H7N7, H7N9, and H5N1, we could demonstrate that strain-specific
phosphorylation of TRIM28 S473 is induced by a signaling cascade constituted of
PKR, p38 MAPK, and MSK1 in response to RIG-I independent sensing of viral RNA.
Furthermore, using chemical inhibitors as well as knockout cell lines, our results suggest
that phosphorylation of S473 facilitates a functional switch leading to increased levels
of IFN-β, IL-6, and IL-8. In summary, we have identified TRIM28 as a critical factor
controlling excessive expression of type I IFNs as well as proinflammatory cytokines
during infection with H5N1, H7N7, and H7N9 HPAIV. In addition, our data indicate a
novel mechanism of PKR-mediated IFN-β expression, which could lay the ground for
novel treatment options aiming at rebalancing dysregulated immune responses during
severe HPAIV infection.
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INTRODUCTION
Influenza A viruses (IAV) are the leading cause of annually
recurring respiratory infections affecting millions of people
worldwide. Infection by seasonal viruses is accompanied by
mild to severe symptoms, such as fever, headache and dry
cough but immunocompetent patients usually recover within 2–
3 weeks. In contrast, infections with highly pathogenic avian
influenza viruses (HPAIV), such as H5N1 often cause severe viral
pneumonia as well as multiple organ failure and can lead to
death, as exemplified by the “bird flu” outbreak in Hong Kong in
1997 with an overall mortality rate of 33% (1–3). Uncontrolled
expression of type I and type II interferons (IFNs) and high
levels of proinflammatory cytokines, such as TNF-α, IL-1ß, IL-
6, und IL-8 due to a hyperinduction of the innate immune and
inflammatory responses are the suspected reasons for HPAIV-
induced immunopathology (reviewed in (4)). The underlying
molecular mechanisms and signaling pathways, which are
responsible for the increased and sustained expression of IFNs
and proinflammatory cytokines during HPAIV infection are
still not fully understood. However, a virus-induced imbalance
of stimulatory and inhibitory factors, which normally regulate
the controlled onset and resolution of immune responses, is
hypothesized (5).
The innate immune response to IAV is rapidly initiated by
pathogen recognition receptors (PRRs), such as RIG-I, which
recognize viral RNA in the cytoplasm of infected cells and
activate a signal transduction cascade involving the adaptor
protein MAVS and the transcription factors IRF3/7. Upon
phosphorylation, IRF3/7 dimerize and translocate into the cell
nucleus where they bind to the IFN-α/β promotor and facilitate
gene transcription. Alternatively, membrane associated toll-
like receptors (TLRs) can detect viral glycoproteins or sense
viral RNA in endosomal compartments and signal via the
adaptor protein MyD88 resulting in the activation of IRF3/5/7
and subsequently in IFN-α/β expression (6, 7). Secreted IFN-
α/β bind to the interferon-α/β receptor on neighboring cells
resulting in STAT1/2 phosphorylation by the receptor-associated
Jak/Tyk kinases (8). This mediates the nuclear translocation
of STATs and upregulation of the expression of hundreds
of interferon-stimulated genes (ISGs), among them antiviral
proteins, chemokines and proinflammatory cytokines. This
allows the recruitment and activation of immune cells at the
site of infection. To resolve the ongoing immune reaction
and prevent immunopathology, negative immune regulators,
such as the recently identified death-associated protein kinase
1 (DAPK1) (9) and others interfere with further signal
transduction and cytokine expression.
Here, we have identified the host factor and
transcriptional corepressor Tripartite motif-containing 28
(TRIM28/KAP1/TIF1β) as a critical regulator of IFN-β, IFN-γ
and cytokine expression during infection with HPAIV. TRIM28
belongs to the family of TRIM proteins (10) of which most
members are involved in the regulation of the immune response
to diverse viruses (11, 12). Like most of the TRIM family
members, TRIM28 possesses E3 ubiquitin ligase activity located
in its N-terminal RBCC-domain. Its C-terminus contains a
rather unique arrangement of functional domains including
a heterochromatin protein 1 binding domain (HP1 BD), a
plant homeodomain (PHD) and a bromodomain (Bromo),
which is only shared by the three other TRIM-family members
TRIM24/TIF1α, TRIM33/TIF1γ and TRIM66/TIF1δ. All
four proteins are known for their function as transcriptional
regulators and constitute the TRIM subfamily VI (13–15).
Functionally, TRIM28 is described as a universal genome
regulator involved in embryonic and stem cell development,
cell cycle regulation, apoptosis, cancer, diverse stress responses
and immunity (16–18). Mice lacking TRIM28 die at an early
embryonic stage emphasizing its crucial role during embryonic
development (19). In addition, TRIM28 facilitates silencing of
endogenous retroviruses (20), restricts pro-viral gene activation
and suppresses lytic gene expression of Kaposi’s sarcoma-
associated herpes virus, Murine leukemia virus and human
T-cell lymphotropic virus-1 (21–23). It possesses E3 SUMO
ligase activity and interacts with diverse transcription factors
and other proteins to modulate their activity. These functions
of TRIM28 are suspected to be regulated by post-translational
modification (PTM) including SUMOylation, phosphorylation
and others, which often occur at acceptor sites located in
close proximity to the functional domains in the C-terminus
(24–26). In contrast to the majority of TRIM proteins,
which comprise immune enhancing activities, TRIM28 is
associated with immunosuppression (27). The protein was
reported to downregulate the activity of several immune-related
transcription factors, such as IRF7, IRF5 and IRF1 as well as
STAT3 by varyingmechanisms (28–30). A role of TRIM28 during
IAV replication has not been investigated until today. First
evidence for a possible functional relevance derives from a global
SUMO-screening demonstrating that TRIM28 is deSUMOylated
during IAV infection (31). Nevertheless, this study did not
address whether TRIM28 is involved in the immune response to
IAV infection.
In the present study, we demonstrate that TRIM28 is
phosphorylated at serine 473 (S473), a site known to regulate
TRIM28 corepressor activity, during infection of human lung
epithelial cells with HPAIV. Furthermore, we establish a
link of S473 phosphorylation to elevated IFN-β expression
and provide compelling evidence that TRIM28 is a key
factor in the development of cytokine overexpression during
HPAIV infection. These results could be the starting point
for the development of new immunomodulatory strategies
targeting TRIM28 post-translational modification to control the
expression of type I IFNs as well as proinflammatory cytokines.
MATERIAL AND METHODS
Cells and Viruses
Human alveolar epithelial cells (A549), African green monkey
kidney epithelial cell (Vero), HEK293T, HEK293T-Phoenix and
Madin-Darby canine kidney type II cells (MDCK-II) were
cultivated in Dulbecco’s modified Eagle’s Medium (DMEM)
(Sigma, Germany) supplemented with 10% fetal bovine serum
(Merck, Germany) and 1% Penicillin/Streptomycin (P/S) (Merck,
Germany) at 37◦C and 5% CO2. Human Umbilical Vein
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Endothelial Cells (HUVECs) were isolated from umbilical
cords by dispase treatment and cultured on CellBIND R© dishes
(Corning, USA) in HUVEC-medium [50% EGM2 and 50%
M199 (Biochrom, Germany) supplemented with 10% fetal
calf serum (Sigma, Germany), 30µg/mL gentamycin (Cytogen,
Germany), 15 ng/mL amphotericin B (Biochrom, Germany),
100 IE Heparin (Ratiopharm, Germany), 2mM L-glutamine
(Lonza, Switzerland)] at 5% CO2 and 37
◦C. Upon infection
HUVECs were cultured in M199 medium containing 1%
BSA, 30µg/ml gentamicin and 15 ng/ml amphotericin B. All
work with HUVECs was conducted with the formal approval
of the Ethics Committee of North Rhine-Westphalia and
the University of Muenster. A/Thailand/KAN-1/2004 (H5N1)
(KAN-1) was kindly provided by P. Puthavathana (Bangkok,
Thailand). A/FPV/Bratislava/79 (H7N7) (FPV) was obtained
from the virus depository of the Institute of Virology in
Giessen, Germany. A/Hamburg/04/2009 (H1N1pdm) was a kind
gift of the German National Reference Centre for Influenza
(Brunhilde Schweiger, Berlin, Germany). A/Vietnam/1203/2004
(H5N1) (VN) and A/Anhui/1/2013 (H7N9) (Anhui) were kindly
offered by Thorsten Wolff (RKI, Berlin). Recombinant A/Puerto
Rico/8/34 (H1N1) (PR8), A/seal/Mass/1-SC35M/80 (H7N7)
(SC35M) and A/WSN/33 (H1N1) (WSN) were generated using
the pHW2000 reverse genetics system (32). All influenza
viruses were propagated on MDCK-II cells in infection
medium [DMEM supplemented with 1% P/S, 0.25% bovine
serum albumin (BSA, Sigma) and 0.01% MgCl2 and CaCl2
(Roth, Germany)]. Infections were carried out by incubating
cells in infection PBS (PBS supplemented with 1% P/S,
0.25% BSA and 0.01% MgCl2 and CaCl2) at the indicated
multiplicity of infection (MOI) for 30min. Experiments
involving HPAIV were conducted in a biosafety level (BSL)
3 approved laboratory. Recombinant VSV (serotype Indiana)
encoding firefly luciferase (VSV-luc) was generated by replacing
the GFP gene in the previously described VSV-GFP vector by
the firefly luciferase gene according to published procedures
(33). VSV-luc was propagated on Vero cells and titrated by
immunostaining with a rabbit polyclonal anti-VSV serum as
described previously (34).
Plasmids
Guide RNAs (gRNA) targeting TRIM28 and mCherry
were designed with BbsI overhang sequences. The gRNA
oligonucleotides were ordered phosphorylated, annealed
and ligated into BbsI digested pSpCas9(BB)-2A-GFP
plasmid (Addgene #48138) (35). For MyD88 and PKR,
gRNAs were annealed, phosphorylated by PNK and cloned
into BsmBI digested lentiCRISPR v2 vector (Addgene
#52961) (36). Oligonucleotide sequences are included in
Supplementary Table S1. Full-length human TRIM28 was
subcloned from pEGFP-TRIM28 (Addgene #45568) into NotI
and XhoI (NEB, USA) digested pBluescript II SK(+/–) vector. In
pBluescript II SK(+/–), TRIM28 mutants (S473A, S473E) were
obtained by site-directed mutagenesis with non-overlapping
primers. Subsequently, TRIM28 wildtype and the phospho-
mutants were cloned into NotI and EcoRI (NEB, USA) digested
retroviral vector pQCXIP. PCR primer sequences are included in
Supplementary Table S2.
Generation of Knockout Cells
A549 TRIM28 CRISPR-Cas9 knockout (KO) and control
cells (Ctrl) were generated by transient transfection. In brief,
A549 cells were transfected with either pSpCas9(BB)-2A-GFP
harboring a gRNA targeting TRIM28 or a control gRNA
targeting mCherry (plasmids were kindly provided by Nicole
Fischer, Hamburg, Germany). Positively transfected cells were
selected by fluorescence-activated cell sorting (FACS) and
clonal cell lines were analyzed for TRIM28 KO by western
blot. A549 PKR, RIG-I KO, MAVS KO and MyD88 KO
cells were generated by lentiviral transduction as described
elsewhere (9, 37). In brief, lentiviral particles were produced
on HEK293T cells by transfection with the following three
plasmids at a 3:1:3 ratio; (i) pCMV-DR8.91 (ii) pMD2.G
(iii) lenti-CRISPR-vector. Virus particle-containing supernatants
were harvested 48, 56, and 72 h post-transfection (h p.t.) and
used for transduction of target cells. Successfully transduced
cells were selected with 1µg/ml puromycin (Sigma, Germany).
Gene knockout in single cell clones was validated by western
blot.
Retroviral Gene Transfer
The empty retroviral vector pQCXIP or pQCXIP-TRIM28
expressing the different phospho-mutants were transfected into
HEK293T-Phoenix packaging cells (Orbigen, USA). Retrovirus-
containing supernatants were harvested 48 and 60 h p.t.,
supplemented with polybrene (Santa Cruz Biotechnology, USA)
to a final concentration of 4µg/ml and used for transduction
of A549 TRIM28 KO cells. Transduced cells were selected with
1µg/ml puromycin for 5 days to obtain stable cell lines and
TRIM28 expression levels were analyzed by western blot. Stable
TRIM28 mutant-expressing cells were subcloned to obtain single
cell clones with equal expression of TRIM28 as measured by
western blot.
Cell Treatments
Cells were treated with inhibitors for 1 h prior to infection,
RNA transfection or induction of genotoxic stress. After
removal of the inoculum, transfection mix or chemicals,
inhibitors were added to the infection medium. The following
inhibitors were used: ATM (KU-60019, Selleckchem, Germany),
Chk2 (Chk2 inhibitor II, Abcam, Germany), p38 MAPK
(SB202190, Calbiochem, USA), PKR (2-Aminopurine, Sigma,
Germany), MEK (U0126, Taros Chemicals, Germany), MK2 (PF-
3644022, Sigma, Germany),MSK1 (SB747651A, AxonMedchem,
Netherlands) and the ROS-scavenging agent N-Acetyl-L-cysteine
(NAC) (Sigma, Germany). Cells were stimulated by exposure to
1 kJ/m2 UVC-light using a Stratalinker 2400 UV Crosslinker
(BioSurplus, USA), or incubation with H2O2, etoposide (Sigma,
Germany) or IFN-β (R&D Systems, Germany) for the indicated
times and concentrations. For RNA and HMW poly(I:C)
(Invivogen, USA) stimulations, A549 cells were transfected
using Lipofectamine 2000TM (Invitrogen, USA) according to
the manufacturer’s instructions. Therefore, total RNA from
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MDCK-II cells either infected with WSN at an MOI of 5
for 8 h or non-infected cells was isolated using the RNeasy
KitTM according to the manufacturer’s instructions (Qiagen,
Germany).
MTT-Assay
For cytotoxicity measurements, MTT [3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide] (Sigma, Germany) was
added to the cells at a final concentration of 5 mg/ml for 4 h at
37◦C and 5% CO2. As a positive control, 2µM staurosporine
(Sigma, Germany) was added for 10 h. Supernatants were
aspirated and DMSO (Roth, Germany) was added for 5min
before the optical density (OD) was measured at a wavelength
of 562 nm (MicroLumat Plus LB96V, Berthold Technologies,
Germany).
Western Blot and Antibodies
Cells were lysed with ice cold radioimmunoprecipitation assay
(RIPA) buffer (25mM TRIS pH 7.5, 150mM NaCl, 0.1% SDS,
0.5% sodium deoxycholate, 1% Triton X-100) supplemented
with the following protease and phosphatase inhibitors;
10µM leupeptin (Sigma, Germany), 200 nM aprotinin (Roth,
Germany), 5mM benzamidine (Sigma, Germany), 2.5mM
pefabloc (Sigma, Germany), 10mM beta-glycerophosphate
(Sigma, Germany), 1mM sodium orthovanadate (Sigma,
Germany), 10mM sodium fluoride (Roth, Germany) and
2.5mM sodium pyrophosphate (Sigma, Germany). Lysates
were sonicated for 20 s (pulse 50%, amplitude 30%) and
pelleted at 4◦C, 14.000 g for 15min. Protein amounts were
adjusted to 20 µg, mixed with 4× sample buffer (0.25M
TRIS pH 6.8, 40% glycerol, 8% SDS, 10% β-mercaptoethanol,
0.01% bromophenol blue) and separated by SDS-PAGE.
Proteins were transferred to nitrocellulose membranes and
detected by using primary antibodies targeting tubulin (Sigma,
Germany), PB1 (GeneTex, USA), TRIM28, TRIM28 S473-P,
TRIM28 S824-P (Abcam, UK), CREB S133-P, RIG-I, eIF2α
S51-P, ERK1/2, ERK1/2 T202/Y204-P, HSP27, HSP27 S82-
P (Cell signaling Technologies, USA) and anti-mouse or
anti-rabbit IgG secondary antibodies either conjugated to
fluorophores (Licor, Germany) or horseradish peroxidase
(Cell Signaling Technology, USA). Selected bands were
densitometrically quantified using Licor Image studio software
(Licor, Germany).
Immunofluorescence
A549 cells were seeded on glass coverslips and fixed with
4% paraformaldehyde (Sigma, USA). Cells were permeabilized
with 0.1% Triton X-100, and blocked for 30min in 3%
BSA. Slides were incubated overnight at 4◦C with primary
antibodies against IAV nucleoprotein (NP) (GeneTex, USA)
and TRIM28 S473-P. Secondary antibodies anti-rabbit Alexa
Fluor 488 (Invitrogen, USA) and anti-mouse Alexa Fluor 568
(Invitrogen, USA) were incubated for 1 h at room temperature.
Cell nuclei were stained for 20min with DAPI (Thermo Fisher
Scientific, USA). Coverslips were mounted on glass slides in
Mounting Medium S3023 (Dako Omnis, USA) and examined
using a LSM-800 Airyscan confocal microscope (Carl Zeiss,
Germany).
Phosphoproteomic Screen
A549 cells were stably labeled with “light” lysine (12C6,
14N2)
and arginine (12C6,
14N4), “medium” lysine (
13C6,
14N2) and
arginine (13C6,
14N2) or “heavy” lysine (
13C6,
15N2) and arginine
(13C6,
15N4). Labeled cells were infected with either PR8, FPV
or KAN-1 at an MOI of 5 for 2, 4, 6, and 8 h. “Light”-
labeled cells were used as non-infected control (0 h), whereas
“medium”- and “heavy”-labeled cells were infected for 2 or 6 h
and 4 or 8 h, respectively. Lysates from non-infected, 2, 4 h
infected cells (Mix 1) and non-infected, 6, 8 h infected cells
(Mix 2) were subjected to tryptic digestion. Phosphopeptides
were purified by cation exchange chromatography and TiO2-
enrichment followed by LC-MS/MS analysis on a Proxeon
Easy-nLC coupled to an LTQ-Orbitrap XL mass spectrometer.
Data analysis was performed using Mascot and MaxQuant
(v1.2.2.9) as previously described (38–40). Phosphorylation
intensities of TRIM28 residues were quantified in relation to the
phosphorylation of TRIM28 in non-infected cells in both lysate
mixtures.
Cytokine Analysis
A549 TRIM28 KO and Ctrl cells were stimulated by transfection
with 200 ng of viral or cellular RNA. The LEGENDplexTM Human
Anti-Virus Response Panel (BioLegend Cat. No. 740350) was
used for the simultaneous determination of the concentrations
of IFN-α, -β, -γ, -λ1 and λ2/3 as well as IL-1β, IL-6,
IL-8, IL-10, IL-12p70, TNF-α, IP-10, and GM-CSF in the
supernatant. Cytokine capturing was performed according to the
manufacturer’s protocol in filter plates. Bead-bound cytokines
were measured on a FACSCalibur Cytometer (Becton Dickinson)
and concentrations were calculated using the LEGENDplexTM
Data Analysis Software (BioLegend, USA).
RNA Isolation and Quantitative Real-Time
PCR (qRT-PCR)
RNA was isolated using peqGOLD TriFastTM according to
the manufacturer’s instructions (VWR, USA). Total RNA was
reverse transcribed with oligo(dT) primers and RevertAid H
Minus Reverse Transcriptase (Thermo Fisher Scientific, USA).
RT-PCR was carried out in duplicates using a LightCycler R©
480 II (Roche, Germany). Primer sequences are provided in
Supplementary Table S3. Commercially available primers were
used for analysis of IFN-βmRNA (Qiagen, Germany). Expression
data were normalized to the housekeeping gene glyceraldehyde
3-phosphate dehydrogenase (GADPH) and analyzed using the
2−11CT method as described elsewhere (41).
IFN-Bioassay
A549 TRIM28 KO and Ctrl cells were stimulated by transfection
of 250 ng of viral or cellular RNA and at 6 h p. t. supernatants
were harvested. The cell-free supernatants were diluted 1:10 and
added to Vero cells for another 16 h. Subsequently, Vero cells
were infected with VSV-luc at an MOI of 5 for 5 h. Supernatants
were aspirated, cells were lysed in passive lysis buffer (Promega,
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USA) and luciferase assay substrate (Promega, USA) was added.
VSV-luc reporter gene expression was determined by measuring
luminescence using a MicroLumat Plus LB96V luminometer
(Berthold Technologies, Germany).
RESULTS
Phosphorylation of TRIM28 Is Induced by
HPAIV Infection
Viruses activate diverse signaling pathways in infected cells.
To elucidate whether human adapted and highly pathogenic
avian-derived IAV strains differentially activate kinase-governed
signaling pathways a quantitative phosphoproteomic screen
was performed (40). Human lung epithelial cells (A549) were
infected with the human IAV strain A/Puerto Rico/8/34 (PR8,
H1N1), the HPAIV strain A/Thailand/KAN-1/2004 (KAN-1,
H5N1), which was isolated from a fatal human case following
direct avian-to-human transmission and the HPAIV avian
isolate A/FPV/Bratislava/79 (FPV, H7N7). This revealed that
the host factor TRIM28 was increasingly phosphorylated at
S473 during infection with KAN-1 and FPV but not with
PR8 (Figure 1A, upper panel). For the neighboring serine 471
(S471), increased phosphorylation was only detected during
FPV infection (Figure 1A, lower panel). These results were
confirmed by western blot analysis using an antibody specific for
phosphorylated TRIM28 S473 (Figure 1B). Based on these data,
we speculated that TRIM28 phosphorylation could be a strain-
dependent mechanism. To support this hypothesis, additional
IAV strains were tested. We observed that TRIM28 S473 was
also phosphorylated upon infection with the mouse-adapted
HPAIV variant A/seal/Mass/1-SC35M/80 (SC35M, H7N7)
and the HPAIV strains A/Vietnam/1203/2004 (VN, H5N1),
A/Anhui/1/2013 (Anhui, H7N9) but not with the human-
adapted 2009 pandemic H1N1 strain A/Hamburg/04/2009
(H1N1pdm) (Figure 1C upper panels). Quantitative western
blot analysis further demonstrated that SC35M, KAN-1, and FPV
induced S473 phosphorylation to different degrees, suggesting
that all three strains have individual capacities to induce S473
phosphorylation (Figures 1B,C, lower panels). Plotting the virus
strains according to the intensity of the induced S473-P signals
indeed suggests that the degree of human adaptation inversely
correlates with the capacity to induce S473 phosphorylation
(Figure 1D). Like H5N1 viruses, H7N7 viruses can cross the
species barrier from birds to humans and may cause severe to
lethal respiratory disease in humans (42–44). As we observed
S473 phosphorylation during infection with the mouse-adapted
HPAIV variant SC35M, we used this strain as a representative
for HPAIV in many experiments. This had the advantage that
we could perform the experiments under BSL2 conditions.
Interestingly, phosphorylation at S473 and S471 could be
detected at 6 h p.i in the phosphoproteomic screen as well as in
western blot analysis, indicating that it is not induced at an early
stage of viral infection like viral entry or nuclear replication but
rather at a later step. S473 phosphorylation was also observed
at a low MOI of 0.1 (Supplementary Figure S1A). In addition,
strain-dependent phosphorylation was also observed in primary
HUVECs (Supplementary Figure S1B). Immunofluorescence
data showed that the occurrence of nuclear S473 phosphorylation
correlates with the cytoplasmic localization of the viral
nucleoprotein (NP) 10 h after infection. In contrast, in cells
infected for 5 h, only background phosphorylation was observed
in the nucleus (Figures 1E,F). In summary, these results
demonstrate that HPAIV of the H5N1, H7N7, and H7N9
subtypes induce phosphorylation of TRIM28 S473 at a late time
point during infection. Furthermore, our data indicate that
the capacity of IAV strains to phosphorylate TRIM28 inversely
correlates with the degree of human adaptation.
HPAIV-Induced Phosphorylation of TRIM28
Is Mediated by a Signaling Pathway not
Related to the DNA Damage Response
(DDR)
Phosphorylation of TRIM28 at positions S473 and serine 824
(S824) is widely described to occur in response to DNA damage
and can be experimentally induced by various genotoxic stresses
including treatment with H2O2, UV-radiation and etoposide
(45–47). During DNA damage, phosphorylation at these sites is
mediated by the kinase ataxia-telangiectasia mutated (ATM) and
the checkpoint kinases 1 und 2 (Chk1/2) (48, 49) (Figure 2A).
Phosphorylation is associated with different biological outcomes.
While S473 is located in close proximity to the HP1 BD,
which mediates the interaction with HP1 and repression
of Krüppel-associated box zinc finger protein (KRAB-ZNF)-
dependent genes, S824 lies next to the C-terminal bromodomain.
Functionally, phosphorylation of S473 has been demonstrated
to ablate binding of TRIM28 to HP1 and TRIM28-mediated
repression of KRAB-ZNF-dependent genes. In contrast, S824
phosphorylation facilitates local chromatin relaxation (48)
and, in combination with TRIM28 deSUMOylation, leads
to the de-repression of DDR-responsive genes (25). Because
infection with IAV has been reported to induce DDR (50,
51), we examined whether infection with SC35M induces
the same phosphorylation pattern on TRIM28 compared to
UV-radiation, H2O2 or etoposide treatment. Remarkably, we
found that the induced phosphorylation patterns during IAV
infection and DNA damage are different. Infection with
SC35M induced phosphorylation of S473 but not S824 while
all three genotoxic agents readily induced phosphorylation
at both sites (Figure 2B). We further investigated whether
ATM and Chk2 are also the responsible kinases for TRIM28
phosphorylation during IAV infection. Treatment of A549
cells with non-toxic concentrations of the inhibitors for ATM
and Chk2 prior to stimulation with H2O2, etoposide or
infection with SC35M clearly demonstrated that these kinases
are not involved in IAV-mediated TRIM28 S473 phosphorylation
(Figure 2C; Supplementary Figures S2A–D). Using NAC to
scavenge reactive oxygen species (ROS) we could also exclude
ROS as cause of TRIM28 S473 phosphorylation during SC35M
infection (Figure 2D). In summary, these results demonstrate
that during IAV infection TRIM28 S473 is not phosphorylated
by the DDR-related kinases ATM and Chk2, which suggests that
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FIGURE 1 | Phosphorylation of TRIM28 during HPAIV infection. (A) SILAC-labeled human A549 cells were infected with FPV (H7N7), KAN-1 (H5N1), and PR8 (H1N1)
for the indicated times at an MOI of 5. Phosphorylated peptides were enriched and analyzed by mass spectrometry. The relative phosphorylation of TRIM28 at serine
473 (S473) and serine 471 (S471) are depicted. Western blot of A549 cells infected with (B) FPV, KAN-1, PR8 and (C) VN (H5N1), Anhui (H7N9), SC35M (H7N7),
H1N1pdm at an MOI of 5 for the indicated time points. Phosphorylation of TRIM28 S473 was detected using a phospho-specific antibody. Detection of total TRIM28
and tubulin served as loading controls. Densitometric quantifications of S473 phosphorylation were normalized to tubulin intensities and are depicted as mean fold
change (±SEM). (D) Schematic representation of mean fold changes of TRIM28 S473 phosphorylation compared to non-infected cells at 6 h p.i. A549 cells were
infected with SC35M (E) at an MOI of 5 for 5 h or (F) at an MOI of 0.5 for 10 h. Nuclei were stained with DAPI. Viral nucleoprotein (NP) and TRIM28 S473
phosphorylation were stained using specific antibodies. Cells were analyzed by confocal laser scanning microscopy.
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FIGURE 2 | Phosphorylation of TRIM28 S473 occurs by non-DDR related kinases during HPAIV infection. (A) Schematic representation of the involved kinases
leading to TRIM28 S473 and S824 phosphorylation during DNA damage response. (B) A549 cells were treated with 250µM H2O2 for 3 h, 100µM etoposide for 6 h,
infected for 10 h with SC35M at an MOI of 20 or treated with 1 kJ/m2 ultraviolet light 30min prior to western blot analysis. TRIM28 phosphorylation was detected
using antibodies specific for TRIM28 phosphorylated at S473 or S824, respectively. Total TRIM28 and tubulin served as loading controls. Infection was validated using
an antibody targeting the viral protein PB1. (C) A549 cells were treated with inhibitors for ATM (KU-60019, 2.5µM), Chk2 (Chk2 Inhibitor II, 10µM) and the solvent
control (DMSO, 10µM) 1 h prior to stimulation with H2O2, etoposide and SC35M infection in the presence of the corresponding inhibitors. (D) A549 cells were treated
with increasing amounts of the reactive oxygen species scavenger NAC (5, 10, 15mM) for 1 h following stimulation with 500µM H2O2 for 2 h and infection with
SC35M for 10 h at an MOI of 20 in the presence of NAC. TRIM28 S473 phosphorylation was monitored by western blot.
TRIM28 has a yet non-described, non-DDR related function in
IAV infected cells.
TRIM28 Is a Negative Regulator of the
Innate Immune Response to IAV
To gain insight into the general function of TRIM28 during
viral infection, TRIM28 KO cells were generated using
CRISPR-Cas9 (Figure 3A). Growth curve analyses demonstrated
no pronounced effect on viral replication of SC35M and
FPV in cells lacking TRIM28 compared to control cells
(Supplementary Figures S3A,B). Because TRIM28 is described
as a negative immune regulator, we analyzed the expression of
IFN-β in these cells. Intriguingly, infection with PR8, SC35M
or FPV resulted in elevated levels of IFN-β compared to
infected control cells (Figure 3B). Elevated levels of IFN-β as
well as the proinflammatory cytokines IL-6 and IL-8 were
also observed during infection of TRIM28 KO cells with
KAN-1 (Figure 3C). In addition, transfection of viral RNA
(vRNA), as a trigger for the innate immune response, also
resulted in higher mRNA levels of IFN-β, IL-6 and IL-8 in
the absence of TRIM28 (Figure 3D). Importantly, we could
also demonstrate that transcriptional upregulation correlated
with significantly increased secretion of IFN-β, IL-6, IL-8 and
IFN-γ in vRNA-treated TRIM28 KO cells at 8 and 24 h p.t.
(Figure 3E; Supplementary Figures S4A,B). Because we did not
observe an effect on SC35M and FPV replication, the biological
function of increased IFN levels was manifested in an IFN-
bioassay using a luciferase-expressing vesicular stomatitis virus
(VSV-luc), which is highly sensitive to the action of IFNs. To
induce an antiviral state, Vero cells were pre-treated with the
supernatants from vRNA-stimulated TRIM28 KO and control
cells. Infection with VSV-luc revealed a pronounced inhibition
of viral replication in Vero cells that have been treated with
the supernatant from stimulated TRIM28 KO cells compared
to Vero cells treated with control cell supernatant, indicating
that the increased IFN levels induced a more potent antiviral
state (Figure 3F). In summary, these results demonstrate that
TRIM28 functions as an important negative regulator of
the expression of IFN-β, IFN-γ, IL-6 and IL-8 during IAV
infection.
Phosphorylation of TRIM28 S473 Occurs in
Response to Viral RNA but Is Independent
of RIG-I
The previous results demonstrated that TRIM28 negatively
regulates the expression of IFN-β, IFN-γ, IL-6 and IL-8 during
IAV infection. However, the role and biological function of
S473 phosphorylation and the source of activation remained
elusive. During IAV infection IFN-β is majorly expressed in
response to sensing of viral RNA by cytosolic RIG-I (52, 53).
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FIGURE 3 | TRIM28 is a negative regulator of the innate immune response during influenza A virus infection. (A) Western blot of A549 TRIM28 KO cells. (B) Infection
of TRIM28 KO cells with PR8, SC35M and FPV at an MOI of 5. Total RNA was isolated at the indicated time points and IFN-β mRNA levels were analyzed by
qRT-PCR. IFN-β levels are depicted as mean n-fold change (±SEM) compared to non-infected cells. **p ≤ 0.002; ***p ≤ 0.0002; two-way ANOVA; Sidak’s multiple
comparisons test. (C) TRIM28 KO cells were infected with KAN-1 (H5N1) at an MOI of 0.01 for 24 h. IFN-β, IL-6 and IL-8 mRNA levels were determined as described
in (B). *p ≤ 0.03; ****p ≤ 0.0001; two-tailed unpaired t-test. (D) TRIM28 KO cells were transfected with 200 ng viral or cellular RNA. Total RNA was isolated 24 h p.t.
and IFN-β, IL-6 and IL-8 mRNA levels were determined by qRT-PCR. Results are shown as mean n-fold change (±SEM) over non-treated cells. **p ≤ 0.0021; ***p ≤
0.0002; two-way ANOVA; Sidak’s multiple comparisons test. (E) TRIM28 KO cells were treated as in (D). Supernatants were analyzed using LEGENDplexTM bead
immunoassay for the indicated cytokines at 24 h p.t. Results of six independent experiments are plotted as well as the mean (±SD). *p ≤ 0.03; ****p ≤ 0.0001;
two-way ANOVA; Tukey’s multiple comparisons test. (F) A549 cells were transfected with 250 ng viral or cellular RNA for 6 h. Supernatants were harvested and
transferred to Vero cells for 16 h. Stimulated Vero cells were infected with a luciferase-encoding vesicular stomatitis virus (VSV-luc) at an MOI of 5 for 5 h. Cells were
harvested and virus replication was determined by luciferase assay. Results of four independent experiments are plotted as well as the mean (±SEM).
Because our results demonstrate that TRIM28 is also involved
in the expression of IFN-β, we speculated that TRIM28 S473
phosphorylation could be induced by a similar mechanism.
Therefore, we analyzed whether transfection of vRNA induces
S473 phosphorylation. We observed that TRIM28 S473 was
markedly phosphorylated following transfection of vRNA or
poly(I:C) (Figure 4A; Supplementary Figure S5A). Importantly,
using RIG-I knockout cells (RIG-I KO) (Figure 4B), we
could demonstrate that S473 phosphorylation during vRNA
transfection (Figure 4C) and SC35M infection (Figures 4D,E)
is retained in the absence of RIG-I. This provides evidence
that S473 phosphorylation occurs independent of the RIG-I
signaling pathway. To support the idea that RIG-I independent
mechanisms contribute to the expression of IFN-β during
infection with HPAIV, we infected wildtype and RIG-I KO
cells with PR8, SC35M as well as FPV and measured the
induction of IFN-β. This revealed that IFN-β expression was
rather low in PR8 infected wildtype cells and seems to primarily
depend on RIG-I as 6.2-fold less IFN-β was induced in the
absence of RIG-I. In contrast, IFN-β was upregulated by
25-fold and 75-fold in SC35M and FPV infected wildtype
cells, respectively. However, lack of RIG-I reduced IFN-β
induction only by 2-fold in SC35M infected cells and 1.5-fold
in FPV infected cells (Figure 4F). This indicates that the
expression of IFN-β during FPV infection is not exclusively
dependent on RIG-I but involves other signaling pathways.
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FIGURE 4 | TRIM28 S473 phosphorylation is induced by viral RNA in a RIG-I independent manner. (A) A549 cells were transfected with 1 µg viral or cellular RNA.
Lysates were harvested 4 h p.t. and TRIM28 S473 and S824 phosphorylation was analyzed by western blot. As a control, cells were treated with 250µM H2O2 for
3 h. (B) Western blot of A549 RIG-I KO cells treated for 24 h with 500 U/ml IFN-β. (C) RIG-I KO cells were transfected with 500 ng viral or cellular RNA. TRIM28 S473
phosphorylation was monitored by western blot. (D) Western blot of TRIM28 S473 phosphorylation in RIG-I KO cells infected with SC35M for 10 h at an MOI of 20.
(E) Densitometric quantifications of S473 phosphorylation in RIG-I KO cells infected as in (D). TRIM28 S473-P levels were normalized to tubulin intensities. Results are
plotted as mean n-fold change (±SEM) over mock-infected cells. n.s. p > 0.03; two-way ANOVA; Tukey’s multiple comparisons test. (F) Infection of RIG-I KO cells
with PR8, SC35M or FPV at an MOI of 5. Total RNA was isolated 8 h p.i. and IFN-β mRNA levels were measured by qRT-PCR. IFN-β levels are depicted as mean
n-fold change (±SEM) over mock-infected cells.
These data suggest that alternative RNA sensing receptors are
responsible for the induction of S473 phosphorylation and
contribute to the high levels of IFN-β during infection with
HPAIV.
Detection of Viral RNA by the Cytoplasmic
RNA Sensor PKR Induces TRIM28 S473
Phosphorylation
To further specify which immune recognition pathway comes
into consideration for S473 phosphorylation and modulation of
IFN-β expression during HPAIV infection, A549 cells lacking the
adaptor proteins MAVS and MyD88 were examined. Infection
with SC35M clearly demonstrated that TRIM28 S473 was still
phosphorylated in cells lacking the RIG-I downstream effector
MAVS, which supported the previous results obtained in RIG-I
KO cells (Figure 5A, lane 7). Of note, RIG-I could not be detected
in this western blot due to low induction by SC35M infection.
However, RIG-I knockout in these cells was demonstrated
following IFN-β treatment in Figure 4B. S473 phosphorylation
was also retained despite lack of MyD88, which rules out the
majority of TLRs as candidate receptors for mediating TRIM28
S473 phosphorylation (Figure 5A, lane 8). Another protein
that is described to have RNA sensing capacity is the double-
stranded RNA sensing protein kinase R (PKR), which also
binds to double-stranded RNAs in the cytosol (54). Interestingly,
inhibition of PKR using 2-Aminopurine (2-AP) impeded S473
phosphorylation in response to viral infection in a concentration
dependent manner (Figure 5B) and following vRNA transfection
(Figure 5D). Furthermore, Figure 5C shows that PKR inhibition
also resulted in decreased levels of IFN-β, IL-6, and IL-8
during infection. As a genetic approach, A549 cells lacking
PKR (PKR KO) were generated. Intriguingly, in these cells S473
phosphorylation after vRNA transfection was strongly reduced
(Figure 5E). Infecting PKR KO cells with PR8, SC35M, and FPV
revealed that the induction of IFN-β is differentially dependent
on PKR. Although all three viruses induce less IFN-β in PKR
KO cells, we observed a clear tendency that IFN-β induction
is more dependent on PKR during infection with SC35M and
FPV compared to PR8 (Figure 5F). This fits to our hypothesis
that IFN-β induction in HPAIV but not PR8 infected cells is
potentiated by a PKR activated signaling cascade. In summary,
these results demonstrate that viral RNA sensing by PKR leads
to TRIM28 S473 phosphorylation during HPAIV infection and
presumably contributes to the high IFN-β levels.
p38 MAPK and MSK1 Phosphorylate
TRIM28 S473 During HPAIV Infection
In order to elucidate the signaling cascade responsible for
TRIM28 S473 phosphorylation during viral infection, we
concentrated further on kinases which are reported to be
involved in the expression of IFN-β and proinflammatory
cytokines during HPAIV infection and are known to be activated
by PKR (55–57). This led us to investigate the stress inducible
mitogen-activated protein kinase (MAPK) p38. Treatment
of A549 cells with the p38 inhibitor SB202190 at specific
and non-toxic concentrations efficiently blocked TRIM28
S473 phosphorylation during SC35M infection (Figure 6A;
Supplementary Figure S6A) demonstrating that p38 plays a
major role in this process. In contrast, treating cells with an
inhibitor of MEK, thus blocking the ERK MAPK pathway, did
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FIGURE 5 | PKR inhibition ablates TRIM28 S473 phosphorylation. (A) A549 RIG-I, MAVS, and MyD88 KO cells were infected with SC35M at an MOI of 20 for 10 h.
TRIM28 S473 phosphorylation was analyzed with a phospho-specific antibody by western blot. Total TRIM28 and tubulin served as loading controls. The viral protein
PB1 was used to verify IAV infection. Expression of MAVS and MyD88 was detected using specific antibodies. (B) A549 cells were treated for 1 h with the PKR
inhibitor 2-AP (0.5, 1, 5 and 10mM). Subsequently, cells were infected with SC35M at an MOI of 20 for 10 h in the presence of 2-AP. (C) A549 cells were pre-treated
with 10mM 2-AP and subsequently infected with SC35M at an MOI of 0.1 for 24 h in the presence of 2-AP. mRNA levels of IFN-β, IL-6 and IL-8 were determined by
qRT-PCR. Results are depicted as mean n-fold change (±SEM) over non-infected cells. *p ≤ 0.03; **p ≤ 0.002; two-tailed unpaired t-test. (D) A549 cells pre-treated
with 10mM 2-AP for 1 h were transfected with 500 ng viral or cellular RNA. Lysates were harvested 4 h p.t. and TRIM28 S473 phosphorylation was analyzed by
western blot. PKR inhibition was controlled by detection of eIF2α S51 phosphorylation. (E) A549 PKR KO cells were transfected with 50, 250, and 500 ng viral RNA or
500 ng cellular RNA. Lysates were harvested 8 h p.t. and TRIM28 S473 phosphorylation was analyzed by western blot. (F) Infection of PKR KO cells with PR8,
SC35M or FPV at an MOI of 5. Total RNA was isolated 8 h p.i. and IFN-β mRNA levels were measured by qRT-PCR. IFN-β levels are depicted as mean n-fold change
(±SEM) over non-infected cells.
not reduce S473 phosphorylation, excluding crosstalk from the
classical MEK1/2-ERK1/2 MAP kinase pathway (Figure 6B;
Supplementary Figure S6B). Well-described downstream
kinases of p38 MAPK are MSK1 and MK2, which are both
reported to be involved in the transcriptional regulation of
cytokine expression (58, 59). Chemical inhibition of MSK1
but not MK2 resulted in the loss of S473 phosphorylation
(Figures 6C,D; Supplementary Figures S6C,D). Importantly,
inhibition of p38 MAPK and MSK1 led to reduced TRIM28 S473
phosphorylation during infection with the HPAIV KAN-1 and
Anhui in primary HUVECs (Supplementary Figures S6F,G).
This led us to conclude that MSK1 is the responsible kinase
for S473 phosphorylation during IAV infection. Induction
of S473 phosphorylation by transfection of vRNA was
similarly abolished by inhibition of p38 and MSK1 but not
by inhibiting MEK and MK2 (Figure 6E). Most importantly,
loss of TRIM28 S473 phosphorylation by inhibition of p38
and MSK1 also resulted in decreased levels of IFN-β, IL-6,
and IL-8 during infection with SC35M (Figure 7A), which was
not caused by an inhibition of viral replication (Figure 7B).
In conclusion, these data provide compelling evidence that
TRIM28 S473 phosphorylation in response to PKR-dependent
sensing of vRNA is mediated by the p38/MSK1-cascade
during infection with HPAIV. Furthermore, these results
strongly indicate that TRIM28 S473 phosphorylation results
in enhanced expression of IFN-β and proinflammatory
cytokines.
Constitutive Phosphorylation of TRIM28
S473 Leads to Increased Induction of
IFN-β, IL-6 and IL-8 During HPAIV Infection
To establish the functional link between TRIM28 S473
phosphorylation and IFN-β expression, we reconstituted
TRIM28 KO cells with either wildtype TRIM28 or the phospho-
mutants S473A and S473E. Infection of TRIM28 KO cells
with VSV-luc resulted in decreased viral replication. Most
importantly, reconstitution of TRIM28 KO cells with the
wildtype protein rescued VSV-luc replication (Figure 8A).
Substitution of S473 with alanine (S473A) eliminates the
phospho-acceptor site, while substitution with glutamic acid
(S473E) mimics constitutive phosphorylation. As our previous
data suggested that S473 phosphorylation regulates TRIM28-
mediated repression of IFN-β, expression of these mutants
should affect VSV-luc replication. Indeed, infection with VSV-
luc demonstrated that reconstitution with TRIM28 S473E
resulted in significantly decreased viral replication compared
to cell expressing wildtype TRIM28 and TRIM28 S473A
(Figure 8B). To proof that expression levels of IFN-β, IL-6, and
IL-8 are also increased in the TRIM28 S473E expressing cells
we infected the reconstituted cells with KAN-1 and performed
qRT-PCR analysis. As seen in Figure 8C, the infected S473E
expressing cells express higher levels of IFN-β, IL-6, and IL-8
compared to cells reconstituted with wildtype TRIM28 and
TRIM28 S473A. Of note, also the non-phosphorylated form of
TRIM28 harboring S473A showed increased levels of IFN-β,
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FIGURE 6 | Inhibition of p38 and MSK1 ablates TRIM28 S473 phosphorylation. A549 cells were pre-treated with inhibitors for (A) p38 (SB202190), (B) MEK (U0126),
(C) MSK1 (SB747651), and (D) MK2 (PF-3644022) at 0.1µM, 0.5µM, 1µM, 5µM and 10µM before infection with SC35M at an MOI of 20 for 10 h and further
incubation with the inhibitors. Lysates were examined with a phospho-specific antibody for TRIM28 S473 phosphorylation. Infection was verified by detection of the
viral PB1 protein. Tubulin and total TRIM28 served as loading controls. MEK and MK2 inhibition was controlled by detection of ERK T202/Y204, and HSP27 S82
phosphorylation, respectively. (E) A549 cells were pre-treated with p38 (SB202190), MEK (U0126), MSK1 (SB747651) and MK2 (PF-3644022) inhibitors at 1µM for
30min. Pre-treated cells were transfected with 500 ng viral or cellular in the presence of the corresponding inhibitors. Lysates were harvested 4 h p.t. and TRIM28
S473 phosphorylation was analyzed by western blot.
FIGURE 7 | Inhibition of p38 and MSK1 downregulates IFN-β, IL-6 and IL-8 expression. (A) A549 cells were pre-treated with inhibitors for p38 (SB202190) and MSK1
(SB747651) and infected with SC35M at an MOI of 0.1 for 24 h in the presence of the inhibitors. IFN-β, IL-6 and IL-8 mRNA levels were determined by qRT-PCR.
Results are depicted as mean n-fold change (±SEM) over non-infected cells. *p ≤ 0.03; **p ≤ 0.0021 one-way ANOVA; Dunnett’s multiple comparisons test.
(B) A549 cells were pre-treated with the MSK1 inhibitor SB747651 for 1 h and subsequently infected with SC35M at an MOI of 0.001. Supernatants were analyzed at
the indicated time points by plaque assay.
IL-6, and IL-8 compared to the cells expressing the wildtype
protein. The reason for this is unknown. We speculate, that other
phosphorylation sites, such as S471 and/or others, compensate
for the lack of S473 phosphorylation. The phosphorylation
dynamics of other phosphorylation sites of TRIM28 are not
well-understood and require further investigation. In summary,
our data demonstrate that S473 phosphorylation is functionally
linked to increased expression of IFN-β, IL-6, and IL-8 and
support our hypothesis, that phosphorylation at S473 modulates
the corepressor activity of TRIM28 during infection with HPAIV.
DISCUSSION
Infection of humans with HPAIV is often associated with
severe tissue damage and multiple organ failure caused
by excessive production of IFNs and proinflammatory
cytokines. The involved pathways as well as the underlying
mechanisms leading to cytokine overexpression are not yet
fully resolved. This knowledge gap impairs the development
of new immunomodulatory treatment options due to the lack
of suitable targets for efficient immunomodulatory therapies.
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FIGURE 8 | Constitutive TRIM28 S473 phosphorylation potentiates the innate immune response. (A) TRIM28 KO cells were stably reconstituted with wildtype
TRIM28 by retroviral transduction. Reconstituted cells were infected with VSV-luc at an MOI of 0.01 for 15 h. Cells were harvested and luciferase activity was
measured. (B) In addition to wildtype TRIM28, phospho-mimetic variants (S473A and S473E) were stably reconstituted in TRIM28 KO cells. VSV-luc infection was
carried out as described in (A). Results are depicted as mean RLU (±SEM) normalized to TRIM28 expression. ****p ≤ 0.0001; one-way ANOVA; Dunnett’s multiple
comparisons test. (C) Stably reconstituted TRIM28 KO cells were infected with KAN-1 at an MOI of 0.01. Total RNA was isolated 24 h p.i. and IFN-β, IL-6 and IL-8
mRNA levels were measured by qRT-PCR. mRNA levels are depicted as mean n-fold change (±SEM) over non-infected cells. n.s. p > 0.03, *p ≤ 0.03; **p ≤ 0.002;
****p ≤ 0.0001; one-way ANOVA; Dunnett’s multiple comparisons test.
FIGURE 9 | Model for TRIM28-mediated upregulation of IFN-β and proinflammatory cytokines during infection with the HPAIV subtypes H5N1, H7N9 and H7N7. Early
during IAV infection, viral RNAs are sensed by RIG-I. This initiates a signaling cascade, which includes the adaptor protein MAVS and results in the dimerization and
nuclear translocation of the transcription factors IRF3/7. During infection with human adapted strains, this leads to non-pathological levels of IFN-β and
proinflammatory cytokines, which usually leads to the clearance of IAV infection (left). In contrast, during infection with the HPAIV of the subtypes H5N1, H7N7 and
H7N9 (right), the expression of IFN-β, IL-6 and IL-8 is potentiated. This is facilitated by PKR-mediated sensing of viral RNA followed by signal transduction via p38 and
MSK1 resulting in phosphorylation of the transcriptional corepressor TRIM28 at serine 473. This leads to the release of TRIM28 corepressor activity and finally results
in elevated expression of IFN-β, IL-6 and IL-8, which is commonly associated with tissue damage und high mortality during HPAIV infections.
Here, we report for the first time, that the cellular corepressor
and negative immune regulator TRIM28 is the direct target of a
signaling cascade involving the kinases PKR/p38/MSK1 during
infection of human alveolar epithelial cells with HPAIV and
contributes to the high expression levels of IFN-β, IL-6 and
IL-8. Based on our results we hypothesize that TRIM28 is a key
determinant for IFN-β overexpression and cytokine-mediated
tissue damage and may represent a potential therapeutic target
for the treatment of HPAIV-induced hypercytokinemia in
humans.
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TRIM28 is widely described as a genomic corepressor and
negative immune regulator of cytokine expression in response
to different immune stimuli. The described mechanisms of
action involve its intrinsic E3 SUMO ligase activity as well
as HP1-BD-mediated corepressor activity, which are assumed
to be fine-tuned by SUMOylation and phosphorylation (24).
The exact contribution of SUMOylation and phosphorylation
to the regulation of TRIM28 activities has remained enigmatic.
However, several reports have established an attractive regulatory
model. While SUMOylation might control the general and
genome wide repressor function of TRIM28, stimulus-dependent
phosphorylation presumably regulates the de-repression of
specific gene subsets (25) to allow stimulus- and stress-specific
host responses. In line with this, Kubota et al. reported that
tyrosine phosphorylation at positions Y449, Y458, and Y517
regulates HP1-binding and the controlled de-repression of genes
required for stress tolerance and repair processes (60) and
Li et al. demonstrated that phosphorylation of S824 regulates
the expression of genes involved in cell cycle control and
apoptosis in response to genotoxic stresses (25). Intriguingly,
the authors of this report observed that the level of TRIM28
SUMOylation was decreased when S824 was mutated to aspartic
acid to mimic constitutive phosphorylation, suggesting PTM
crosstalk (25). Our own data suggest that phosphorylation of
TRIM28 at S473 regulates the de-repression of IFN-β, IL-6 and
IL-8. Nevertheless, we assume that additional sites could be
involved, as we observed phosphorylation of the neighboring
serine 471 in our phosphoproteomic screen (Figure 1A, lower
panel). Supportive evidence for the biological relevance of
phosphorylation of S473 and S471 comes from other proteomic
studies in which these sites have been identified as phospho-
acceptor sites (61, 62). In addition, both sites are also highly
conserved in mice, rats and dogs, suggesting a biological
important function. The p38/MSK1/TRIM28 signaling-axis
was described previously to play a central role in myoblast
differentiation. In these cells, TRIM28 phosphorylation controls
the activity of the central transcriptional activator MyoD and
thereby differentiation of myoblasts into myotubes (63). In
addition, this report convincingly demonstrated that TRIM28
is a bona fide target of MSK1 in an in vitro kinase
assay.
The detailed mechanism of TRIM28-mediated cytokine
amplification during HPAIV infection remained unsolved. Based
on available reports we assume that phosphorylation at S473
attenuates HP1- and chromatin-binding of TRIM28, which
results in the loss of its corepressor function and leads to
the de-repression of the described genes (49). However, other
mechanism cannot be excluded. Because TRIM28 itself does not
possess DNA binding activity, it is likely that cytokine repression
occurs through the interaction with other transcription factors
and chromatin remodeling enzymes. Indeed, TRIM28 was shown
to interact and modulate the activity of diverse immune-related
proteins, including NF-κB (64), STAT1 (28), STAT3 (29), IRF7
(30), and IRF5 (65). Nevertheless, a conjoint conclusion for the
mode of action of TRIM28 is difficult to extract because diverse
cell lines and immune stimuli were employed and the impact
of S473 phosphorylation was not addressed. Thus, it needs to
be investigated whether one of these factors facilitates TRIM28-
mediated cytokine upregulation upon S473 phosphorylation.
Recently, a novel model for TRIM28-mediated control of gene
expression was proposed (66, 67). In this model, TRIM28
is involved in tethering of the 7SK snRNP complex to the
promotor proximal regions of many rapid response genes that
contain paused RNA Polymerase II (Pol II). Thereby, TRIM28
facilitates recruitment of the positive transcription elongation
factor P-TEFb, which releases paused Pol II by phosphorylating
serine 2 in the pol II C-terminal domain (CTD) and allows
rapid elongation of transcription (62, 67, 68). Most intriguingly,
TRIM28 was found to be associated with more than 13,000
promotor proximal regions, giving a rough estimation of how
many genes might be regulated by TRIM28 (69). So far, the
importance of S473 phosphorylation and SUMOylation for the
control of immune-related genes has not yet been addressed in
this model.
Phosphorylation of TRIM28 S473 was induced in a strain-
dependent manner. This suggests that the degree of human
adaptation as well as the reported characteristic to induce
hypercytokinemia and tissue damage in humans might be
determinants for TRIM28 phosphorylation during infection.
To challenge this theory, we included the pandemic 2009
H1N1 virus in our analysis because it is a triple reassortant
virus containing genes derived from humans, swine and birds
and has acquired stepwise human adaptation in pigs prior to
human transmission. In contrast to other pandemic IAV strains,
H1N1pdm demonstrated weak virulence and low mortality rates
(70) and human infections with this virus are not necessarily
associated with hypercytokinemia and tissue damage. Thus, we
expected that this strain would not trigger S473 phosphorylation.
Indeed, we could not detect S473 phosphorylation with
H1N1pdm, supporting our hypothesis (Figure 1C). The reasons
for strain-dependent phosphorylation of TRIM28 on a molecular
level are not known. It is tempting to speculate that it is
mediated by virus intrinsic properties, such as avian specific
protein signatures, differences in the NS1-mediated inhibition of
PKR activation or other factors that underlie human adaptation.
Alternatively, differences in replication speed or nuclear export
of vRNPs, leading to accumulation of cytosolic vRNA cannot be
excluded.
In addition to the novel role of TRIM28, our results suggest
a new mechanism for PKR-mediated cytokine expression. Here,
PKR senses viral RNA at a late time point during infection
with HPAIV and provokes TRIM28 S473 phosphorylation via
p38 and MSK1 with the consequence of excessive production
of IFN-β, IL-6 and IL-8. PKR-mediated regulation of IFN-β
expression in virus infected cells is described to be facilitated
by activation of the translation elongation factor eIF2α as well
as by compromised IFN-β mRNA stability (71, 72). Here we
show, that in HPAIV-infected cells, PKR signals via p38/MSK1
to inactivate TRIM28 and potentiates the expression of IFN-β,
IL-6 and IL-8 in human lung epithelial cells. At this moment,
it remains unknown whether this pathway is also present in
other IAV susceptible cell types, such as macrophages and
dendritic cells, which could have severe immunopathological
consequences as these cells are the main producers of IFNs and
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cytokines. The results from the phosphoproteomic screen as well
as western blot analysis demonstrate that S473 phosphorylation
occurs at a surprisingly late time point during infection.
We assume that PKR activation requires the accumulation
of viral RNA in the cytoplasm, possibly in the form of
exported vRNPs, in order to boost IFN-β and cytokine
expression through S473 phosphorylation. This mechanism of
PKR activation has been previously suggested for Influenza
B viruses (73) but is not described for IAV. Although our
results convincingly show that TRIM28 phosphorylation is
mediated by PKR, we can currently not exclude that other
signaling pathways and receptors, such as TLR3, which signals
independently of the adaptor proteins MyD88 and MAVS, are
also involved.
In summary, we propose a model for the TRIM28-mediated
potentiation of cytokine expression during HPAIV infection.
During infection with human adapted IAV strains, viral RNA
is detected early during infection by RIG-I, which leads
to the expression of non-pathological levels of IFN-β and
proinflammatory cytokines (Figure 9, left side). In contrast,
during infection with HPAIV of the H5N1, H7N7, and H7N9
subtypes cytosolic viral RNA is recognized by PKR, in addition
to the RIG-I-dependent antiviral response. This leads to the
activation of p38 andMSK1 and subsequently to phosphorylation
of TRIM28 at S473 with the consequence of exacerbation of
the ongoing immune response by amplification of IFN-β, IL-6
and IL-8 expression, which may lead to excessive immune cell
recruitment and tissue inflammation (Figure 9, right side). We
therefore propose, that controlling phosphorylation of TRIM28
by therapeutic interventions could prevent uncontrolled cytokine
expression during HPAIV infections in humans.
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